FDA Expands Indication for Several Transcatheter Heart Valves to Patients at Low Risk [1]
The FDA-approved use of TAVR has now expanded to low-risk patients with severe aortic stenosis. This includes both Edwards Lifesciences' Sapien 3 and Sapien 3 Ultra as well as Medtronic's Evolut R and Evolut PRO.
Source name:
US Food and Drug Administration
Resource link:
Subspecialty(ies):
Cardiac [6]
Taxonomy2018 vocabulary term reference:
Aorta 5 [7]